#75 – Breakpoints Talks Breakpoints: Aminoglycosides
Breakpoints
00:00
The History of Breakpoints in the M100
I would really encourage our audience to look at the comment next to the aminoglycosides in the new M100 because I think again, you know, some of the limitations that Mike put on the availability of the data. Usually for serious infections, we'd like to see a one log kill if possible. That data on systemic infections outside the urinary tract are quite limited. And that combination therapy for other indications should be considered.
Transcript
Play full episode
